Belmar Pharma Solutions Revenue and Competitors

Golden, CO USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Belmar Pharma Solutions's estimated annual revenue is currently $25.3M per year.(i)
  • Belmar Pharma Solutions's estimated revenue per employee is $201,000

Employee Data

  • Belmar Pharma Solutions has 126 Employees.(i)
  • Belmar Pharma Solutions grew their employee count by 26% last year.

Belmar Pharma Solutions's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Information OfficerReveal Email/Phone
3
Chief Growth OfficerReveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
PharmacistReveal Email/Phone
7
Account CoordinatorReveal Email/Phone
8
West Regional Account ManagerReveal Email/Phone
9
Portal Development & Implementation | Trainer | Physician Relations | Project ManagementReveal Email/Phone
10
Lead Validation EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$10.3M516%N/AN/A
#3
$4.4M22-8%N/AN/A
#4
$195M1220%$121.4MN/A
#5
$4.8M24-20%N/AN/A
#6
$6.8M34-19%N/AN/A
#7
$4.8M240%N/AN/A
#8
$4M40-11%$138MN/A
#9
$4.8M24-14%N/AN/A
#10
$69.5M346-6%N/AN/A
Add Company

What Is Belmar Pharma Solutions?

Since 1985, Belmar Pharmacy has specialized in compounded oral, sublingual and topical dosage forms. What sets us apart is our unique BLAâ„¢ (Bioavailable Lymphatic Absorption) lipid matrix tablet system designed for oral HRT; our exclusive paraben-free, petroleum-free hormone cream base; and our outstanding customer service and value. Our goal is better patient outcomes, through quality compounding, and effective communication between practitioner, pharmacist and patient.

keywords:N/A

N/A

Total Funding

126

Number of Employees

$25.3M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$43.9M133-1%N/A
#2
$39.2M135-3%N/A
#3
N/A1365%N/A
#4
$13.8M1385%N/A
#5
$49.7M1488%N/A